How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care ...

NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...

Women aged 40 and older with node-positive early breast cancer, a group traditionally routed straight to chemotherapy, may ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...